Los Angeles Capital Management LLC Nurix Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 26,544 shares of NRIX stock, worth $712,971. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,544
Previous 33,245
20.16%
Holding current value
$712,971
Previous $693,000
14.14%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NRIX
# of Institutions
180Shares Held
68.1MCall Options Held
78KPut Options Held
53.8K-
Black Rock Inc. New York, NY6.82MShares$183 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.28MShares$115 Million6.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$108 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$104 Million0.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.87MShares$104 Million3.2% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.27B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...